Mird237

Given that MIRD237 is not for human use, human safety data does not exist. However, acute toxicology studies in Sprague-Dawley rats have established a No Observed Adverse Effect Level (NOAEL) at doses up to 10 mg/kg subcutaneously. Higher doses (25 mg/kg and above) produced transient lethargy and mild injection site erythema.

Observed side effects in animal models include:

Absolute contraindications for research: Do not use MIRD237 in pregnant or lactating animals, or in subjects with known hypersensitivity to peptide-based compounds. mird237

Because MIRD237 includes standardized phantoms for children (newborn, 1-year, 5-year, 10-year, 15-year) and pregnant women at various trimesters, it remains the only globally accepted standard for protecting vulnerable populations. If a pregnant patient requires I-131 therapy for thyroid cancer, the fetal thyroid dose is estimated using MIRD237-derived S-values.

If you are a nuclear medicine physician, oncologist, or radiology resident, you do not need to memorize MIRD237’s 200+ pages of tables. However, you should understand: Given that MIRD237 is not for human use,

For laboratory use only, the standard protocol for MIRD237 reconstitution and administration is as follows:

Note: Intranasal or oral routes of administration are not effective due to the peptide’s instability in gastric fluids and large molecular size. Absolute contraindications for research: Do not use MIRD237

Entry ID: MIRD-237 Studio: MOODYZ (Moodys) Series: MIRD Series (often associated with the "Gati" or specific thematic lines) Release Date: May 2023 Classification: Adult Video (AV)